Clinical trial
Pilot Study Combining Temozolomide, Oncovin, Camptosar and Oral Antibiotic in…
NCT00222443 · University of Oklahoma, Other · Completed
Key facts
| NCT number | NCT00222443 |
|---|---|
| Title | Pilot Study Combining Temozolomide, Oncovin, Camptosar and Oral Antibiotic in Children and Adolescents With Recurrent Malignancy |
| Official title | Pilot Study Combining Temozolomide, Oncovin, Camptosar and Oral Antibiotic in Children and Adolescents With Recurrent Malignancy |
| Lead sponsor | University of Oklahoma, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lymphomas, Tumors |
| Intervention type | Drug |
| Interventions | Irinotecan |
| Enrollment | 40 |
| Start date | Sep 1, 2004 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Sep 22, 2005 |
| Last update posted | Sep 22, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: